# Famotidine for Levodopa-induced Dyskinesia in PD

> **NCT01937078** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 7 (actual)

## Conditions studied

- Dyskinesia

## Interventions

- **DRUG:** Famotidine

## Key facts

- **NCT ID:** NCT01937078
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2014-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01937078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01937078, "Famotidine for Levodopa-induced Dyskinesia in PD". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01937078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*